Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 05, 2015 11:35 AM ET

Biotechnology

Company Overview of NanoValent Pharmaceuticals, Inc.

Company Overview

NanoValent Pharmaceuticals, Inc. develops drug delivery vaccines and cancer applications for Polymerized Liposomal Nanoparticles (PLNs). The company was founded in 2006 and is based in Bozeman, Montana.

910 Technology Boulevard

Suite G

Bozeman, MT 59718

United States

Founded in 2006

Phone:

406-586-8420

Fax:

406-586-8421

Key Executives for NanoValent Pharmaceuticals, Inc.

President
Co-Founder and Chief Technology Officer
Chief Medical Officer
Age: 70
Compensation as of Fiscal Year 2015.

NanoValent Pharmaceuticals, Inc. Key Developments

NanoValent and NanoSmart Enter into a Strategic Research Collaboration to Develop Enhanced Cancer Pharmaceuticals

NanoSmart (R) and NanoValent have entered into a research collaboration agreement to explore the feasibility of jointly developing an ANA-conjugated liposomal doxorubicin nanoparticle for the treatment of ovarian cancer and other solid tumors. The joint project combines NanoValent's hybrid polymerized liposomal nanoparticle (HPLN), which can be loaded with chemotherapeutic substances for safer drug delivery, and NanoSmart's patented anti-nuclear antibody (ANA), a platform technology that targets areas of necrosis present in all solid tumors.

NanoValent Pharmaceuticals, Inc. Presents at 15th Annual SoCalBio Investor & Partnership Conference, Nov-06-2013 09:45 AM

NanoValent Pharmaceuticals, Inc. Presents at 15th Annual SoCalBio Investor & Partnership Conference, Nov-06-2013 09:45 AM. Venue: Omni Hotel, 251 South Olive Street, Los Angeles, CA 90012, United States.

Similar Private Companies By Industry

Company Name Region
Deerland Enzymes, Inc. United States
Gene-Fresh Technologies United States
Neurome, Inc. United States
TVAX Biomedical, Inc. United States
Edwards Lifesciences Cardiovascular Resources Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NanoValent Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.